INTELLIA THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
INTELLIA THERAPEUTICS, INC. (NTLA) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $56.10 million as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2024-02-22
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $56.10M.
- 2023-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $69.20M.
- 2023-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $83.10M.
- 2023-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $94.80M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2023-12-31 | $56.10M 10-K · filed 2024-02-22 |
| 2023-09-30 | $69.20M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $83.10M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $94.80M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $93.10M 10-K · filed 2023-02-23 |
| 2022-09-30 | $106.50M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $120.90M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $132.30M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $130.30M 10-K · filed 2022-02-24 |
| 2021-09-30 | $120.80M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $91.60M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $86.90M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $33.70M 10-K · filed 2021-02-26 |
| 2020-09-30 | $35.50M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $39.10M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $39.30M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $28.20M 10-K · filed 2020-02-27 |
| 2019-09-30 | $30.90M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $34.10M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $37.00M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $38.20M 10-K · filed 2019-02-27 |
| 2018-09-30 | $30.10M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $37.90M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $39.20M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $27.20M 10-K · filed 2018-03-14 |
| 2017-09-30 | $22.70M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $24.50M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $25.00M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $13.50M 10-K · filed 2017-03-14 |
| 2016-09-30 | $15.40M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $15.10M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $11.80M 10-Q · filed 2016-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |